Therefore, we found that DKK1 level was negatively correlated with bone formation biomarker of ALP and lumbar BMD, Z scores of BMD at lumbar spine and femoral neck, indicating that DKK1 had the potential as a novel biochemical marker for OI patients. The gene discussed is DKK1; the disease is osteogenesis imperfecta.